News: Quality of Care

Next Page »« Previous Page

Clinical Trials in Era of Targeted Therapies

Friday, December 17th, 2010

Cousins with melanoma caused by the same genetic mutation enroll in a randomized clinical trial of a promising experimental drug that targets the mutation. Randomly assigned to different groups, one young man gets the new drug, experiences dramatic shrinkage of his tumors and is alive nine months later, while his cousin receives current therapy — […]

Oncology Clinic Takes Magnet to Heart

Friday, November 19th, 2010

Vanderbilt-Ingram Cancer Center’s Oncology Clinic in Cool Springs makes patient care its priority, and provides a strong example of why the Medical Center is deserving of a second Magnet designation. Though the clinic is 16 miles from the main Vanderbilt University Medical Center campus, the culture of this suburban clinic embodies the VUMC Nursing philosophy […]

VUMC Joins Blood-Brain Barrier Group

Friday, November 12th, 2010

Vanderbilt University Medical Center has joined the International Blood-Brain Barrier Consortium, a group that is combining research and comprehensive patient care to develop protocols and guidelines for opening the blood-brain barrier. The blood-brain barrier is a system of tight junctions in the circulatory system around the brain that protects the central nervous system from unsafe […]

Grants to Fund Research on Early Detection

Thursday, November 4th, 2010

The National Cancer Institute has awarded two Early Detection Research Network (EDRN) grants to a group of Vanderbilt-Ingram Cancer Center investigators to support early detection of lung and colon cancers. Pierre Massion, M.D., associate professor of Medicine and Cancer Biology, has been awarded $3 million over five years for the creation of the Vanderbilt Clinical […]

Writing Workshop for Cancer Survivors

Monday, October 18th, 2010

Cancer survivors interested in exploring the process of creative writing are eligible to attend free Vanderbilt writing workshops this fall. The classes are open to all cancer survivors regardless of where they received their cancer care, and previous writing experience is not required. Participants will have the opportunity to create original material and share their […]

New Grant Boosts Prostate Cancer Research

Thursday, October 7th, 2010

Vanderbilt-Ingram Cancer Center has received a $7.6 million American Recovery and Reinvestment Act of 2009 (ARRA) stimulus grant to coordinate a study comparing the effectiveness of various treatments for prostate cancer. Funded by the Agency for Healthcare Research and Quality, the three-year grant is part of the CHOICE award program that uses federal ARRA stimulus […]

Meeting Explores Cancer’s Impact on Heart

Tuesday, September 28th, 2010

Well-known daytime television actor Anthony Herrera will be the featured guest speaker at this year’s Cardiology & Oncology International Symposium, Thursday, October 7, at the Sheraton Nashville Downtown Hotel. This year’s Cardiology & Oncology International Symposium is designed to help medical professionals identify and screen cancer patients for cardiovascular disease and manage treatment for cancer […]

More Breast Services at One Hundred Oaks

Friday, September 17th, 2010

Beginning Sept. 20, Vanderbilt-Ingram Cancer Center (VICC) will begin consolidating additional breast cancer services, including chemotherapy, at Vanderbilt Health One Hundred Oaks. In addition to undergoing surveillance and diagnostic testing at the Vanderbilt Breast Center, breast cancer patients will be able to see their physicians and receive chemotherapy in one convenient location, without moving back […]

Approach Eases Adrenal Tumor Removal

Friday, September 10th, 2010

Surgeons at the Vanderbilt Endocrine Surgery Center recently performed an innovative procedure, and Tennessee’s first, that is paving the way for easier, less painful removal of adrenal tumors. By making just three small incisions to the back, James Broome, M.D., and Carmen Solorzano, M.D., were able to remove a benign tumor from a patient using […]

New Melanoma Drug Creates Excitement

Thursday, September 2nd, 2010

A new drug used to treat advanced melanoma patients with a specific genetic mutation in their tumors demonstrated significant tumor shrinkage in the majority of patients during a clinical trials.